Alan Tan

8PUBLICATIONS

91CO-AUTHORS

Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 03, 2026

Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).

|Apr 19, 2026

Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial.

|Mar 05, 2026

Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.

Yu-Wei Chen, Joanne Xiu, Kelsey Anne Poorman

|Feb 03, 2026

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

George Ansstas, Karam Khaddour, Sumedha Sudhaman

|Nov 03, 2025

IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.

David H Aggen, Meredith McKean, Jean H Hoffman-Censits

|Sep 24, 2025

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Rebecca Hassoun, Reuben Ben-David, John P Sfakianos

Pageof 2

Frequent Collaborators

Minetta C Liu

Cherry Au

Himisha Beltran

Adam C ElNaggar

Shuang George Zhao

Matthew D Galsky

Rana R McKay

Yu-Wei Chen

Jeannie Hoffman-Censits

1 joint publications

Arnab Basu

Frequent Collaborators

Minetta C Liu

Cherry Au

Himisha Beltran

Adam C ElNaggar